American Bio Medica Corporation Announces Fiscal Year End 2004 Conference Call.

KINDERHOOK, N.Y. -- American Bio Medica Corporation (NASDAQ:ABMC), a global provider of immunoassay diagnostic test kits, will release fiscal year end 2004 results at close of market on Wednesday, March 23, 2005. The Company will hold a conference call to discuss the year end 2004 results on Thursday, March 24, 2005, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

This call is being webcast by CCBN and can be accessed at ABMC's web site at www.abmc/investor.com

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

About ABMC

American Bio Medica Corporation is a biotechnology company that develops manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R) and RDS(R) InCup(TM) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader(TM) is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.